Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 5, 2011, Pages 1423-1429

  Chen, Allen M ^a   Farwell, D Gregory ^a   Luu, Quang ^a   Chen, Leon M ^a   Vijayakumar, Srinivasan ^a   Purdy, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Head and neck cancer; Intensity modulated radiotherapy; Marginal miss

Indexed keywords

CLINICAL TARGET VOLUMES; CONCURRENT CHEMOTHERAPY; HEAD-AND-NECK CANCER; HYPOPHARYNX; IN-FIELD RECURRENCE; INTENSITY-MODULATED RADIOTHERAPY; LYMPH NODE REGION; MARGINAL MISS; MEDICAL RECORD; ORAL CAVITY; OROPHARYNX; PAROTID GLANDS; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKS; TARGET VOLUMES;

CHEMOTHERAPY; DISEASES; PATIENT MONITORING; RADIOTHERAPY;

PHYSICAL THERAPY;

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; FEMALE; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX CANCER; HYPOPHARYNX SQUAMOUS CELL CARCINOMA; INTENSITY MODULATED RADIATION THERAPY; LARYNX CANCER; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; MULTIPLE CYCLE TREATMENT; OROPHARYNX CANCER; OROPHARYNX SQUAMOUS CELL CARCINOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECURRENT CANCER; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960089463     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.04.011     Document Type: Article

References (31)

1. W.M. Mendenhall, and A.A. Mancuso Radiotherapy for head and neck cancer: Is the "next level" down? Int J Radiat Oncol Biol Phys 73 2009 645 646
2. P.M. Harari Beware the swing and a miss: Baseball precautions for conformal radiotherapy Int J Radiat Oncol Biol Phys 70 2008 657 659 (Pubitemid 351199741)
3. W.R. Lee Technology assessment: Vigilance required Int J Radiat Oncol Biol Phys 70 2008 652 653 (Pubitemid 351199717)
4. V. Gregoire, A. Eisbruch, and M. Hamoir Proposal for the delineation of the nodal CTV in the node-positive and post-operative neck Radiother Oncol 2006 15 20
5. S. Apisarnthanarax, D.D. Elliott, and A.K. El Naggar Determining optimal clinical target volume in head and neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT Int J Radiat Oncol Biol Phys 53 2002 1174 1184
6. I. Poon, N. Fischbein, and N. Lee A population-based atlas and clinical target volume for the head and neck lymph nodes Int J Radiat Oncol Biol Phys 59 2004 1301 1311 (Pubitemid 38960764)
7. C. Rasch, R. Steenbakkers, and M. van Herk Target definition in prostate, head, and neck Semin Radiat Oncol 15 2005 136 145 (Pubitemid 40835955)
8. F.L. Greene, D.L. Page, and I.D. Fleming AJCC Staging Manual (ed 6) 2002 Springer-Verlag New York, NY
9. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 547 581
10. L.A. Dawson, Y. Anzai, and L. Marsh Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 46 2000 1117 1126 (Pubitemid 30139420)
11. A. Eisbruch, L.H. Marsh, and L.A. Dawson Recurrences near base of skull after IMRT for head and neck cancer: implications for target delineation in high neck and for parotid gland sparing Int J Radiat Oncol Biol Phys 59 2004 28 42 (Pubitemid 38501504)
12. K.S.C. Chao, G. Ozyigit, and B.N. Tran Patterns of failure in patients receiving definitive and postoperative IMRT for head and neck cancer Int J Radiat Oncol Biol Phys 55 2003 312 321 (Pubitemid 36069088)
13. J.P. Logue, C.L. Sharrock, and R.A. Cowan Clinical variability of target volume description in conformal radiotherapy planning Int J Radiat Oncol Biol Phys 41 1998 929 931 (Pubitemid 28285974)
14. P. Nowak, O.B. Wijers, and F.J. Lagerwaard A three-dimensional CT-based target definition for elective irradiation of the neck Int J Radiat Oncol Biol Phys 45 1999 33 39 (Pubitemid 29380071)
15. P.M. Som, H.D. Curtin, and A.A. Mancuso Imaging-based nodal classification for evaluation of neck metastatic adenopathy AJR Am J Roentgenol 174 2000 837 845
16. O.B. Wijers, P.C. Levendag, and T. Tan A simplified CT-based definition of the lymph node levels in the node negative neck Radiother Oncol 52 1999 35 42 (Pubitemid 29461094)
17. P. Levendag, M. Braaksma, and E. Coche Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American academy of otolaryngology-head and neck surgery Int J Radiat Oncol Biol Phys 58 2004 113 123 (Pubitemid 38010344)
18. DAHANCA, EORTC, GORTEC, NCIC and RTOG endorsed consensus guidelines for the delineation of the CTV in the N0 neck of patients with head and neck squamous cell carcinoma. http://www.rtog.org/atlases/hnatlas/main.html. Accessed December 1, 2008.
19. M. Palazzi, B.A. Fossa-Jereczeck, and C. Soatti CT-based delineation of lymph node levels in the neck: Can we optimize the consensus? Radiother Oncol 73 2004 383 386 (Pubitemid 39601089)
20. A. Eisbruch, and V. Gregoire Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer Semin Radiat Oncol 19 2009 43 52
21. D.M. Cannon, and N.Y. Lee Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 70 2008 660 665 (Pubitemid 351199716)
22. G.O. Schoenfeld, R.J. Amdur, and C.G. Morris Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 71 2008 377 385
23. N. Lee, P. Xia, and N.J. Fischbein Intensity-modulated radiation therapy for head and neck cancer: the UCSF experience focusing on target volume delineation Int J Radiat Oncol Biol Phys 57 2003 49 60 (Pubitemid 36959738)
24. D.R. Gomez, J.E. Zhung, and J. Gomez Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers Int J Radiat Oncol Biol Phys 73 2009 1096 1103
25. N. Lee, C. Chuang, and J. Quivey Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma Int J Radiat Oncol Biol Phys 53 2002 630 637 (Pubitemid 34632602)
26. M.E. Daly, Y. Lierskovsky, and T. Pawlicki Evaluation of patterns of failure and subjective salivary function in patients treated with intensity-modulated radiotherapy of head and neck squamous cell carcinoma Head Neck 29 2007 211 220 (Pubitemid 46339317)
27. D.I. Rosenthal, M.S. Chambers, and C.D. Fuller Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer Int J Radiat Oncol Biol Phys 72 2008 747 755
28. J.A. Purdy Dose to normal tissues outside the radiation therapy patient's treated volume: A review of different radiation therapy techniques Health Phys 95 2008 666 676
29. D. Khuntia, J. Harris, and S.M. Bentzen Increased oral mucositis after IMRT versus non-IMRT when combined with cetuximab and cisplatin or docetaxel for head and neck cancer: preliminary results of RTOG 0234 Int J Radiat Oncol Biol Phys 72 2008 S33
30. M. Yao, K. Chang, and G.F. Funk Intensity-modulated radiotherapy for head and neck squamous cell carcinoma: the University of Iowa experience Int J Radiat Oncol Biol Phys 63 2005 410-421
31. G. Studer, R.A. Zwahlen, and K.W. Graetz IMRT in oral cavity cancer Radiat Oncol 2 2007 16 23